Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2014-07-31 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Financial Results For 4th Qtr 14 & Fiscal Year 2014 6 pages 262.1KB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of financial results for the fourth quarter and fiscal year ended June 30, 2014, including revenue, net income, earnings per share, operating expenses, and cash flow. It contains comprehensive financial data such as condensed consolidated statements of income and balance sheets, as well as reconciliations of GAAP and non-GAAP financial measures. The presence of quarterly and annual financial figures, detailed analysis, and discussion of business outlook indicates this is a comprehensive financial report for a fiscal year and quarter. The document is not merely an announcement or summary but includes substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR) because it covers a quarter and the fiscal year but is not a full annual report (10-K). The document also includes a dividend declaration and share repurchase information, which are typical in quarterly earnings releases but the primary content is the detailed financial results and analysis. Hence, the best classification is Interim / Quarterly Report (IR). Q4 2014
2014-07-31 English
Q4 & Fiscal Year-End, 2014 Results Conference Call 1
Regulatory Filings Classification · 95% confidence The document is a short announcement (2024 characters) stating that ResMed will report its fourth quarter and fiscal year-end 2014 results on a future date (July 31, 2014). It includes details about the timing of the earnings release, webcast information, and replay instructions. There are no actual financial results or substantive financial data presented in this document. It is clearly an announcement of an upcoming earnings release and webcast, not the earnings release itself or a detailed financial report. According to the 'MENU VS MEAL' rule, such a short announcement about a future report is classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR).
2014-07-10 English
Becoming a substantial holder 4 pages 153.5KB
Major Shareholding Notification Classification · 95% confidence The document is very short (1062 characters) and contains tabular data listing registered holders and their shareholdings. There are no financial statements, management commentary, or detailed report content. The content resembles a notification of share ownership levels or changes in significant shareholdings. There is no indication of an annual report, earnings release, or other detailed filings. Given the presence of specific shareholding numbers and entities, the document fits best as a Major Shareholding Notification (MRQ).
2014-07-09 English
Conflict Minerals Report of ResMed Inc. 7 pages 87.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'FORM SD Specialized Disclosure Report' filed with the SEC, specifically a Conflict Minerals Report for the calendar year ended December 31, 2013. It references compliance with the Securities Exchange Act of 1934, Section 13(p), Rule 13p-1, which mandates disclosure about conflict minerals. The document contains detailed due diligence information, analysis, and results related to conflict minerals sourcing. It is not an annual report, earnings release, or management discussion but a specialized disclosure report focused on conflict minerals. The length is 9492 characters, which is substantive and contains detailed content, not just an announcement or certification. Therefore, the document fits the category of a Regulatory Filing (RNS) as it is a specialized disclosure report required by SEC regulations but does not fit into other more specific categories like Annual Report or Earnings Release.
2014-06-02 English
EXCHANGE RATE FOR UPCOMING DIVIDEND PAYMENT 1 page
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from ResMed Inc. regarding the exchange rate for an upcoming dividend payment. It specifies the dividend amount, payment date, and currency exchange details for shareholders. There is no detailed financial data, comprehensive report, or management discussion. The document is clearly an announcement about dividend payment details rather than the dividend declaration itself or a full financial report. Given the content and length (2536 characters), this fits the category of a Notice of Dividend Amount (DIV).
2014-05-21 English
Appendix 3B 8 pages 248.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about securities issued or repurchased, number of securities, issue price, purpose of the issue, and related ASX rules. The content focuses on share repurchase and capital changes, including the number of shares repurchased and the impact on issued shares. There is no financial performance data, management discussion, or earnings information. The document is regulatory in nature, specifically related to capital structure changes and securities issuance. This matches the definition of a Share Issue/Capital Change announcement (SHA). The document is not a full financial report, earnings release, or management report, but a formal announcement of capital changes to the stock exchange.
2014-05-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.